{"id":"NCT00788593","sponsor":"Forest Laboratories","briefTitle":"A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)","officialTitle":"A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 in Chronic Pancreatitis (CP) Patients With Exocrine Pancreatic Insufficiency (EPI)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-03","completion":"2009-03","firstPosted":"2008-11-11","resultsPosted":"2014-03-12","lastUpdate":"2014-03-12"},"enrollment":82,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pancreatitis","Exocrine Pancreatic Insufficiency"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"EUR-1008 (APT-1008) High Dose","otherNames":["Zenpep"]},{"type":"DRUG","name":"EUR-1008 (APT-1008) Low Dose","otherNames":["Zenpep"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"EUR-1008 (APT-1008) High Dose","type":"EXPERIMENTAL"},{"label":"EUR-1008 (APT-1008) Low Dose","type":"EXPERIMENTAL"}],"summary":"The primary efficacy objective of this study is to evaluate the difference in coefficient of fat absorption (CFA) of participants treated with high dose EUR-1008 (APT-1008) versus low dose of EUR-1008 (APT-1008) in the treatment of signs and symptoms of malabsorption in participants with EPI associated with CP. This study is sponsored by Aptalis Pharma (formerly Eurand).","primaryOutcome":{"measure":"Percent Coefficient of Fat Absorption (CFA) of Participants Treated With High Dose EUR-1008 and Low Dose EUR-1008","timeFrame":"3 to 5 days of hospital treatment in first and second intervention periods","effectByArm":[{"arm":"EUR-1008 (APT-1008) Low Dose","deltaMin":88.87,"sd":12.44},{"arm":"EUR-1008 (APT-1008) High Dose","deltaMin":89.86,"sd":8.77}],"pValues":[{"comp":"OG000 vs OG001","p":"0.228"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":21},"locations":{"siteCount":18,"countries":["United States","Italy","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":82},"commonTop":["Flatulence","Abdominal pain","Diarrhoea","Headache","Constipation"]}}